Your search for bevacizumab returned 51 results

Genentech announced positive results from its Phase 3 study of Avastin (bevacizumab) plus radiation and temozolomide (Temodar; Merck & Co., Inc.) chemotherapy in patients with newly diagnosed glioblastoma.